Multidrug-Resistant Organism (MDRO) Consulting Service
The Multidrug-Resistant Organism (MDRO) Consulting Service translates theory into practice by offering a new and innovative approach to address the continuing challenge of health care–associated infections. JCR's expert consultants in infection prevention and control and health care epidemiology will position organizations to implement cutting edge, evidence-based processes to prevent and control MDROs in the hospital based on unique characteristics. The value of this service lies in the potential for significant cost savings and the improvement of patient safety and quality of care associated with an effective MDRO prevention and control program. In an era of mandatory public reporting and disclosure, the JCR MDRO Consulting Service will prepare your organization to meet regulatory standards and legislative mandates while reducing institutional liability.
This will include:
·
A comprehensive, objective assessment of an organization's institutional risk for MDROs and the capacity to address prevention of MDROs such as methicillin-resistant Staphylococcus aureus (MRSA)
·
A critical analysis of the essential elements of an effective MDRO prevention and control program directed by state of the art guidelines and literature from the CDC, APIC, SHEA, and The Joint Commission
·
A collaboratively developed, tailored action plan for systematically implementing cutting edge, evidenced-based processes to prevent and control MDROs based on an organization's specific characteristics
·
Building the necessary internal expertise and knowledge transfer required to proactively approach the management and control of existing and emerging infections
Contact our Consulting Services group to find out how our solutions can be uniquely tailored to the needs of your organization.
By phone 630.268.7400 or email at ConsultingServices@jcrinc.com
Download the MDRO service brochure
Item Number:
CONS-MDRO